# HealOr

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/healor

- Industry: Biotechnology
- Headquarters: Rehovot, Israel
- Website: www.healor.com
- Total disclosed funding: $16M
- Latest round: Series C (Nov 4, 2010)
- Investors on record: 1

## About

HealOr Ltd. is a healthcare provider that focuses on comprehensive primary care services, including hormone therapy, medical weight loss, and various specialized treatments aimed at enhancing patient health and well-being.Founded in 2002 and headquartered in Rehovot, Israel, HealOr Ltd. is dedicated to providing a wide array of healthcare services. The company raised USD 7.5 mn in Series C financing on November 4, 2010, from Pitango Venture Capital, marking a significant milestone in its funding journey. HealOr has executed a total of 2 deals since its inception.HEALOR Clinic specializes in a comprehensive range of primary care services designed to meet the diverse healthcare needs of patients in Las Vegas, NV, and beyond. Their core offerings include personalized primary care, hormone replacement therapy for both men and women, medical weight loss programs, erectile dysfunction treatments, female sexual health solutions, and IV therapy. The clinic emphasizes a holistic approach to healthcare, combining modern medicine with integrative care practices tailored to individual patient needs, serving individuals seeking preventive care and chronic condition management.HEALOR Clinic generates revenue through direct patient transactions for its diverse range of healthcare services. Patients schedule appointments to receive care, including consultations for primary care, hormone therapy, and other specialized treatments. The clinic employs a fee-for-service model, allowing patients to pay for individual services rendered. Key services such as hormone replacement therapy and medical weight loss programs significantly contribute to its revenue stream, with a focus on building lasting client relationships.HealOr Ltd. plans to utilize the recent funding of USD 7.5 mn raised in Series C financing to enhance its service offerings and expand its geographic reach. The company is designing new healthcare products and exploring opportunities to enter additional markets, with a focus on regional expansions beyond its current locations, aiming for implementation in the next few years. The funding will support these initiatives and boost its capacity to deliver high-quality patient-centered care.

## Funding rounds

- Series C, Nov 4, 2010, $7.5M — Pitango
- Series B, Nov 1, 2007, $8M — Pitango

## Investors

- Pitango (https://capitalatlas.ai/funds/pitango) — Series B, Series C